Phase II Randomized Trial Comparing PLA to HIGRT Therapy (PROVE-HCC)

Condition:   Hepatocellular Carcinoma Interventions:   Procedure: Percutaneous Local Abalation;   Radiation: Hypofractionated Image Guided Radaition Therapy Sponsors:   Duke University;   Durham VA Medical Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials